Skip to content
PICO Portalanswers from OpenAlex

MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF

PaperCitations, authors & open-access status

MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is a paper indexed in PICO Portal from OpenAlex.

How many citations does MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF have?

PICO Portalcitation count

MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF has 56 citations in the OpenAlex counts PICO Portal stores.

When was MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF published?

PICO Portalyear

MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF has 2019 year in the PICO Portal index.

What is the open-access status of MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?

PICO Portaloa status

MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF has gold oa status in the PICO Portal index.

What is the DOI of MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?

PICO Portaldoi

The DOI for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is on the source record.

What is the PMID of MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?

PICO Portalpmid

The PMID for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is on the source record.

What is the OpenAlex record for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?

PICO Portalopenalex

The OpenAlex for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial